Key takeaways Ozempic is an FDA approved drug that contains the active ingredient semaglutide
Generics for exenatide (Bydureon), liraglutide (Saxenda) and dulaglutide (Trulicity) could be available in 2027
Nadk was the rate-limiting enzyme that phosphorylated NAD to NADP and is highly conserved throughout biological evolution
The FDA warning letter from February 2026 flagged misleading marketing language, not an accusation that the company is a scam, but it is a documented regulatory concern worth factoring in
What makes it a better choice: Comprehensive coverage for foundational daily nutrient support Women-focused formulation instead of a generic multivitamin approach Twice-daily dosing , which can support better absorption and gentler tolerance for some women Bioavailable nutrients , which matter when digestion and intake are already compromised Support for energy, metabolism, hair, skin, immune health, and overall resilience For women on GLP-1, that combination matters